

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 8.82497226 |
| 2 | sequestering of actin monomers (GO:0042989) | 7.87670964 |
| 3 | cellular response to interleukin-15 (GO:0071350) | 7.68938772 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.11917962 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.87248906 |
| 6 | negative thymic T cell selection (GO:0045060) | 6.73399759 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.71625134 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.71625134 |
| 9 | response to interleukin-15 (GO:0070672) | 6.67082787 |
| 10 | negative T cell selection (GO:0043383) | 6.65229681 |
| 11 | leukocyte aggregation (GO:0070486) | 6.52710360 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.50431073 |
| 13 | thymic T cell selection (GO:0045061) | 6.40808792 |
| 14 | lymphocyte costimulation (GO:0031294) | 6.39215099 |
| 15 | T cell costimulation (GO:0031295) | 6.36466392 |
| 16 | positive T cell selection (GO:0043368) | 5.92544273 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.83360140 |
| 18 | T cell receptor signaling pathway (GO:0050852) | 5.76143009 |
| 19 | tolerance induction (GO:0002507) | 5.74376254 |
| 20 | positive regulation of interleukin-8 secretion (GO:2000484) | 5.59189210 |
| 21 | T cell selection (GO:0045058) | 5.52861445 |
| 22 | DNA deamination (GO:0045006) | 5.47145364 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 5.43613533 |
| 24 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.36780942 |
| 25 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.96509196 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.87300433 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.87300433 |
| 28 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.81571373 |
| 29 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.77535364 |
| 30 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.73150788 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 4.60466655 |
| 32 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.45822627 |
| 33 | regulation of respiratory burst (GO:0060263) | 4.36185275 |
| 34 | response to type I interferon (GO:0034340) | 4.36052691 |
| 35 | cellular response to type I interferon (GO:0071357) | 4.35346555 |
| 36 | type I interferon signaling pathway (GO:0060337) | 4.35346555 |
| 37 | natural killer cell activation (GO:0030101) | 4.31938869 |
| 38 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.29008249 |
| 39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.27423703 |
| 40 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.25371727 |
| 41 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.25371727 |
| 42 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.13343700 |
| 43 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.13343700 |
| 44 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.13096410 |
| 45 | interferon-gamma production (GO:0032609) | 4.09749150 |
| 46 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.06784021 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.02689349 |
| 48 | positive regulation of lamellipodium assembly (GO:0010592) | 4.01969121 |
| 49 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.01509223 |
| 50 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.98911593 |
| 51 | regulation of response to interferon-gamma (GO:0060330) | 3.97620150 |
| 52 | T cell migration (GO:0072678) | 3.97616711 |
| 53 | positive regulation of macrophage differentiation (GO:0045651) | 3.92637424 |
| 54 | positive regulation of tolerance induction (GO:0002645) | 3.85576474 |
| 55 | cellular extravasation (GO:0045123) | 3.85031975 |
| 56 | mast cell activation (GO:0045576) | 3.83578791 |
| 57 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.79854775 |
| 58 | regulation of cell killing (GO:0031341) | 3.79811162 |
| 59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.78641643 |
| 60 | regulation of defense response to virus by virus (GO:0050690) | 3.72678497 |
| 61 | regulation of hypersensitivity (GO:0002883) | 3.63791920 |
| 62 | positive regulation of cell killing (GO:0031343) | 3.63632527 |
| 63 | positive regulation of humoral immune response (GO:0002922) | 3.63049886 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.60820441 |
| 65 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.59518414 |
| 66 | positive regulation of lamellipodium organization (GO:1902745) | 3.54294784 |
| 67 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.47605601 |
| 68 | heterotypic cell-cell adhesion (GO:0034113) | 3.46776662 |
| 69 | T cell differentiation (GO:0030217) | 3.45359713 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45072969 |
| 71 | T cell activation (GO:0042110) | 3.40949863 |
| 72 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.40370470 |
| 73 | regulation of necroptotic process (GO:0060544) | 3.37065320 |
| 74 | regulation of B cell mediated immunity (GO:0002712) | 3.35016133 |
| 75 | positive regulation of interferon-gamma production (GO:0032729) | 3.34991727 |
| 76 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.33138907 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 3.32710366 |
| 78 | regulation of tolerance induction (GO:0002643) | 3.28650220 |
| 79 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.27492332 |
| 80 | positive regulation of T cell activation (GO:0050870) | 3.26325179 |
| 81 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.24947816 |
| 82 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.24192567 |
| 83 | positive regulation of B cell mediated immunity (GO:0002714) | 3.24192567 |
| 84 | regulation of isotype switching (GO:0045191) | 3.22102485 |
| 85 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.21509349 |
| 86 | positive regulation of interleukin-2 production (GO:0032743) | 3.21395420 |
| 87 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21010570 |
| 88 | regulation of immunoglobulin production (GO:0002637) | 3.18233135 |
| 89 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.18147770 |
| 90 | cellular response to interleukin-4 (GO:0071353) | 3.18082450 |
| 91 | regulation of interleukin-8 secretion (GO:2000482) | 3.15812140 |
| 92 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.15442633 |
| 93 | regulation of T cell mediated immunity (GO:0002709) | 3.14703025 |
| 94 | cytokine biosynthetic process (GO:0042089) | 3.14318109 |
| 95 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.12022357 |
| 96 | membrane raft organization (GO:0031579) | 3.11045619 |
| 97 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.09640311 |
| 98 | regulation of regulatory T cell differentiation (GO:0045589) | 3.09609399 |
| 99 | negative regulation of stress fiber assembly (GO:0051497) | 3.09445543 |
| 100 | regulation of interleukin-4 production (GO:0032673) | 3.08927007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.90654523 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.46255164 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.59077868 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.41988457 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.14987208 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.82667212 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.80276494 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.52334462 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.42627367 |
| 10 | MAF_26560356_Chip-Seq_TH1_Human | 3.10949042 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 3.09389052 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 3.08916091 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.01819032 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.98681240 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94857702 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90037109 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.87390565 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.61790125 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.44154606 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.30099772 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27642741 |
| 22 | MAF_26560356_Chip-Seq_TH2_Human | 2.27437755 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.22402863 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99850646 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.95841086 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.92376845 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88946874 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85080444 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82903107 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.82619949 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78206168 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71682163 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71458403 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70209296 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66674801 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64981881 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.62174511 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57959774 |
| 39 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56598238 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55523928 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48476833 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40572885 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39475024 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38621815 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38555781 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37207929 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34443588 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32424045 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28453821 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23815365 |
| 51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23723987 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23151888 |
| 53 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.21279554 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20613172 |
| 55 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19140383 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19106270 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17457076 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13921166 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13013276 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12149315 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10908999 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.10041916 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09878092 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09008986 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08040953 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07797545 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07721361 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04626795 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03292377 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02697765 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02016074 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01714288 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00186102 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99244412 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96958801 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96907976 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94419956 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93890691 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92840922 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92772394 |
| 81 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.92218937 |
| 82 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.91293603 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.90449746 |
| 84 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89154752 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85890379 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85400051 |
| 87 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85339650 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83937802 |
| 89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83300373 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80490577 |
| 91 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77563709 |
| 92 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.75989260 |
| 93 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.75130561 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74918997 |
| 95 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.74426122 |
| 96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74136647 |
| 97 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.74077766 |
| 98 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.73700765 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72358004 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 0.71363383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.13624544 |
| 2 | MP0005671_abnormal_response_to | 6.05162949 |
| 3 | MP0002166_altered_tumor_susceptibility | 4.33997344 |
| 4 | MP0001835_abnormal_antigen_presentation | 4.20687914 |
| 5 | MP0009785_altered_susceptibility_to | 3.63090871 |
| 6 | MP0000685_abnormal_immune_system | 3.56214018 |
| 7 | MP0002006_tumorigenesis | 3.32786894 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.19006509 |
| 9 | MP0001800_abnormal_humoral_immune | 2.99331131 |
| 10 | MP0005387_immune_system_phenotype | 2.97511058 |
| 11 | MP0001790_abnormal_immune_system | 2.97511058 |
| 12 | MP0005025_abnormal_response_to | 2.85417057 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.82701572 |
| 14 | MP0001819_abnormal_immune_cell | 2.79855870 |
| 15 | MP0002723_abnormal_immune_serum | 2.79080972 |
| 16 | MP0002398_abnormal_bone_marrow | 2.76874984 |
| 17 | MP0006082_CNS_inflammation | 2.70038966 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.67292647 |
| 19 | MP0003724_increased_susceptibility_to | 2.53746425 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.49149899 |
| 21 | MP0000716_abnormal_immune_system | 2.48550175 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.41552465 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.38088839 |
| 24 | MP0002722_abnormal_immune_system | 2.37626170 |
| 25 | MP0002933_joint_inflammation | 2.30073086 |
| 26 | MP0004510_myositis | 2.27874114 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.15661492 |
| 28 | MP0002405_respiratory_system_inflammati | 2.14872091 |
| 29 | MP0003866_abnormal_defecation | 2.09181025 |
| 30 | MP0002396_abnormal_hematopoietic_system | 2.01890066 |
| 31 | MP0005310_abnormal_salivary_gland | 2.01689727 |
| 32 | MP0002429_abnormal_blood_cell | 1.97098101 |
| 33 | MP0004381_abnormal_hair_follicle | 1.96038038 |
| 34 | MP0002419_abnormal_innate_immunity | 1.87192139 |
| 35 | MP0001873_stomach_inflammation | 1.80890580 |
| 36 | MP0004947_skin_inflammation | 1.80458510 |
| 37 | MP0001348_abnormal_lacrimal_gland | 1.74277302 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.66716632 |
| 39 | MP0003436_decreased_susceptibility_to | 1.65526662 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.50308079 |
| 41 | MP0001853_heart_inflammation | 1.47916187 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.45243614 |
| 43 | MP0002009_preneoplasia | 1.39543941 |
| 44 | MP0008469_abnormal_protein_level | 1.35131777 |
| 45 | MP0000858_altered_metastatic_potential | 1.33773708 |
| 46 | MP0009764_decreased_sensitivity_to | 1.24074454 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.20970855 |
| 48 | MP0003303_peritoneal_inflammation | 1.10967548 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.05734083 |
| 50 | MP0001851_eye_inflammation | 1.02349743 |
| 51 | MP0003448_altered_tumor_morphology | 1.01938844 |
| 52 | MP0002163_abnormal_gland_morphology | 1.01576615 |
| 53 | MP0002019_abnormal_tumor_incidence | 0.96513656 |
| 54 | MP0009763_increased_sensitivity_to | 0.90482165 |
| 55 | MP0002132_abnormal_respiratory_system | 0.88823670 |
| 56 | MP0001533_abnormal_skeleton_physiology | 0.83544319 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 0.77996308 |
| 58 | MP0002998_abnormal_bone_remodeling | 0.77755387 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 0.74983432 |
| 60 | MP0000015_abnormal_ear_pigmentation | 0.70732309 |
| 61 | MP0005023_abnormal_wound_healing | 0.69891212 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 0.67976156 |
| 63 | MP0000343_altered_response_to | 0.66376589 |
| 64 | MP0000477_abnormal_intestine_morphology | 0.65571775 |
| 65 | MP0002822_catalepsy | 0.64707853 |
| 66 | MP0002693_abnormal_pancreas_physiology | 0.64290146 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.62740884 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 0.61801302 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 0.55956492 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.55956492 |
| 71 | MP0000490_abnormal_crypts_of | 0.55068195 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.53845130 |
| 73 | MP0008872_abnormal_physiological_respon | 0.52024051 |
| 74 | MP0003795_abnormal_bone_structure | 0.51598236 |
| 75 | MP0000249_abnormal_blood_vessel | 0.50163520 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 0.48473684 |
| 77 | MP0000609_abnormal_liver_physiology | 0.48216692 |
| 78 | MP0009379_abnormal_foot_pigmentation | 0.48023855 |
| 79 | MP0002909_abnormal_adrenal_gland | 0.47136078 |
| 80 | MP0009840_abnormal_foam_cell | 0.46911904 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 0.45968118 |
| 82 | MP0001191_abnormal_skin_condition | 0.43390157 |
| 83 | MP0003045_fibrosis | 0.40458021 |
| 84 | MP0000604_amyloidosis | 0.39611213 |
| 85 | MP0001663_abnormal_digestive_system | 0.38665978 |
| 86 | MP0000313_abnormal_cell_death | 0.38531081 |
| 87 | MP0002928_abnormal_bile_duct | 0.37283209 |
| 88 | MP0001764_abnormal_homeostasis | 0.36964323 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.35424666 |
| 90 | MP0002083_premature_death | 0.34816120 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.34068501 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.33013687 |
| 93 | MP0000598_abnormal_liver_morphology | 0.32848410 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.30785274 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.30724205 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 0.30724190 |
| 97 | MP0003879_abnormal_hair_cell | 0.28749626 |
| 98 | MP0008873_increased_physiological_sensi | 0.27978783 |
| 99 | MP0008770_decreased_survivor_rate | 0.27128608 |
| 100 | MP0005451_abnormal_body_composition | 0.26808985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.81380817 |
| 2 | Severe combined immunodeficiency (HP:0004430) | 7.60078747 |
| 3 | Abnormality of T cell number (HP:0011839) | 7.44469736 |
| 4 | Recurrent bronchitis (HP:0002837) | 6.79247569 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.73068747 |
| 6 | Combined immunodeficiency (HP:0005387) | 6.70442734 |
| 7 | IgG deficiency (HP:0004315) | 6.21988401 |
| 8 | Hypoplasia of the thymus (HP:0000778) | 5.94111114 |
| 9 | Thyroiditis (HP:0100646) | 5.91750564 |
| 10 | IgM deficiency (HP:0002850) | 5.85861757 |
| 11 | Abnormality of T cells (HP:0002843) | 5.74209082 |
| 12 | Increased IgM level (HP:0003496) | 5.44186352 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.17955093 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 5.17955093 |
| 15 | Abnormality of B cell number (HP:0010975) | 5.00059903 |
| 16 | B lymphocytopenia (HP:0010976) | 5.00059903 |
| 17 | Stomatitis (HP:0010280) | 4.91804429 |
| 18 | Chronic diarrhea (HP:0002028) | 4.87842000 |
| 19 | Abnormality of eosinophils (HP:0001879) | 4.76305406 |
| 20 | Lymphopenia (HP:0001888) | 4.38511926 |
| 21 | Myositis (HP:0100614) | 4.20121506 |
| 22 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.15333457 |
| 23 | Autoimmune hemolytic anemia (HP:0001890) | 4.02340057 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.82541001 |
| 25 | Bronchitis (HP:0012387) | 3.79881458 |
| 26 | Leukocytosis (HP:0001974) | 3.75517784 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.73049872 |
| 28 | Recurrent sinusitis (HP:0011108) | 3.38036101 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.32695385 |
| 30 | IgA deficiency (HP:0002720) | 3.29603763 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 3.09143207 |
| 32 | Recurrent otitis media (HP:0000403) | 3.03054982 |
| 33 | Vasculitis (HP:0002633) | 2.98525516 |
| 34 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.94553977 |
| 35 | Eczematoid dermatitis (HP:0000976) | 2.92895029 |
| 36 | Orchitis (HP:0100796) | 2.92601063 |
| 37 | Lymphoma (HP:0002665) | 2.92299873 |
| 38 | Chronic otitis media (HP:0000389) | 2.88726421 |
| 39 | Eosinophilia (HP:0001880) | 2.78840342 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.76555751 |
| 41 | Microcytic anemia (HP:0001935) | 2.76085917 |
| 42 | Joint swelling (HP:0001386) | 2.75063843 |
| 43 | Recurrent skin infections (HP:0001581) | 2.72403085 |
| 44 | Obstructive lung disease (HP:0006536) | 2.56740134 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56740134 |
| 46 | Pustule (HP:0200039) | 2.56654615 |
| 47 | Large eyes (HP:0001090) | 2.56213925 |
| 48 | Recurrent viral infections (HP:0004429) | 2.54679965 |
| 49 | Optic neuritis (HP:0100653) | 2.52395418 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.52395418 |
| 51 | Panhypogammaglobulinemia (HP:0003139) | 2.47912958 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.47907420 |
| 53 | Granulocytopenia (HP:0001913) | 2.47024646 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.43152664 |
| 55 | Type 2 muscle fiber atrophy (HP:0003554) | 2.40907146 |
| 56 | Hypoproteinemia (HP:0003075) | 2.35243076 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.31985037 |
| 58 | Nasal polyposis (HP:0100582) | 2.31653130 |
| 59 | Poikiloderma (HP:0001029) | 2.28481638 |
| 60 | Muscle fiber atrophy (HP:0100295) | 2.28325214 |
| 61 | Abnormality of the nasal mucosa (HP:0000433) | 2.27787408 |
| 62 | Hemoptysis (HP:0002105) | 2.22076325 |
| 63 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.18955955 |
| 64 | Meningitis (HP:0001287) | 2.16274510 |
| 65 | Radial bowing (HP:0002986) | 2.12027150 |
| 66 | Mediastinal lymphadenopathy (HP:0100721) | 2.03533436 |
| 67 | Gingivitis (HP:0000230) | 2.02637978 |
| 68 | Anorexia (HP:0002039) | 2.01921098 |
| 69 | Entropion (HP:0000621) | 1.97725689 |
| 70 | Abnormality of the fingertips (HP:0001211) | 1.97647000 |
| 71 | Thrombocytosis (HP:0001894) | 1.95182191 |
| 72 | Basal cell carcinoma (HP:0002671) | 1.93526535 |
| 73 | Sepsis (HP:0100806) | 1.92451415 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 1.87593456 |
| 75 | Skin rash (HP:0000988) | 1.86748763 |
| 76 | Urticaria (HP:0001025) | 1.83497024 |
| 77 | Spontaneous hematomas (HP:0007420) | 1.83261415 |
| 78 | Gingival bleeding (HP:0000225) | 1.77375579 |
| 79 | Emphysema (HP:0002097) | 1.76991768 |
| 80 | Epistaxis (HP:0000421) | 1.75180547 |
| 81 | Pulmonary embolism (HP:0002204) | 1.72646625 |
| 82 | Gangrene (HP:0100758) | 1.71493287 |
| 83 | Ureteral stenosis (HP:0000071) | 1.70650926 |
| 84 | Arthralgia (HP:0002829) | 1.70480349 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 1.68898494 |
| 86 | Premature skin wrinkling (HP:0100678) | 1.68627463 |
| 87 | Abnormality of macrophages (HP:0004311) | 1.67907928 |
| 88 | Encephalitis (HP:0002383) | 1.66976881 |
| 89 | Bronchiectasis (HP:0002110) | 1.65827043 |
| 90 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.65482563 |
| 91 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.65482563 |
| 92 | Abnormality of the pleura (HP:0002103) | 1.64282125 |
| 93 | Polyneuropathy (HP:0001271) | 1.63518686 |
| 94 | Petechiae (HP:0000967) | 1.63463665 |
| 95 | Bicuspid aortic valve (HP:0001647) | 1.61632101 |
| 96 | Facial edema (HP:0000282) | 1.61600867 |
| 97 | Periorbital edema (HP:0100539) | 1.61011528 |
| 98 | Abnormality of the prostate (HP:0008775) | 1.59461236 |
| 99 | Abnormality of the thymus (HP:0000777) | 1.58240801 |
| 100 | Increased density of long bones (HP:0006392) | 1.58221655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.09037672 |
| 2 | KDR | 5.32091927 |
| 3 | MAP4K1 | 4.08829388 |
| 4 | ZAP70 | 4.01732848 |
| 5 | TESK2 | 3.24408362 |
| 6 | MAP3K12 | 3.15437414 |
| 7 | FGFR4 | 2.98659785 |
| 8 | BLK | 2.93178183 |
| 9 | IKBKE | 2.88269974 |
| 10 | NME2 | 2.85497788 |
| 11 | ITK | 2.47670818 |
| 12 | TYK2 | 2.20866584 |
| 13 | TBK1 | 2.11574132 |
| 14 | JAK1 | 2.04917936 |
| 15 | JAK3 | 2.04136622 |
| 16 | LCK | 1.92259917 |
| 17 | TEC | 1.91328678 |
| 18 | GRK6 | 1.88272848 |
| 19 | ERN1 | 1.84490536 |
| 20 | SYK | 1.83505725 |
| 21 | NLK | 1.70827613 |
| 22 | BTK | 1.62100192 |
| 23 | HCK | 1.54102048 |
| 24 | FGFR3 | 1.52735545 |
| 25 | CSK | 1.51757051 |
| 26 | TESK1 | 1.43771660 |
| 27 | EIF2AK1 | 1.26641004 |
| 28 | KIT | 1.20993059 |
| 29 | TNK2 | 1.18752945 |
| 30 | STK10 | 1.16438048 |
| 31 | MYLK | 1.09906711 |
| 32 | MAP3K14 | 1.00989480 |
| 33 | TLK1 | 0.98989199 |
| 34 | DAPK3 | 0.98763854 |
| 35 | LYN | 0.98517265 |
| 36 | MAP2K6 | 0.96447049 |
| 37 | IRAK4 | 0.92989605 |
| 38 | SIK1 | 0.91922071 |
| 39 | FYN | 0.86326566 |
| 40 | NEK9 | 0.85141724 |
| 41 | PRKCQ | 0.82489220 |
| 42 | SCYL2 | 0.80840343 |
| 43 | SIK2 | 0.79683849 |
| 44 | LIMK1 | 0.75768631 |
| 45 | SIK3 | 0.75301253 |
| 46 | INSR | 0.72335737 |
| 47 | FLT3 | 0.64664516 |
| 48 | LRRK2 | 0.62939528 |
| 49 | PDGFRB | 0.61418695 |
| 50 | CLK1 | 0.60239543 |
| 51 | PRKCH | 0.59105756 |
| 52 | EIF2AK3 | 0.55136523 |
| 53 | JAK2 | 0.54497610 |
| 54 | DAPK1 | 0.52210498 |
| 55 | ILK | 0.50831812 |
| 56 | FGFR1 | 0.48967245 |
| 57 | IKBKB | 0.48469956 |
| 58 | PDK4 | 0.45810855 |
| 59 | PDK3 | 0.45810855 |
| 60 | IGF1R | 0.45302112 |
| 61 | TGFBR2 | 0.41973355 |
| 62 | FGFR2 | 0.40790862 |
| 63 | MAP2K7 | 0.40369548 |
| 64 | MAPK11 | 0.39308586 |
| 65 | ROCK1 | 0.39057445 |
| 66 | CSF1R | 0.36732299 |
| 67 | MARK2 | 0.34932404 |
| 68 | MAP3K13 | 0.34190388 |
| 69 | FES | 0.33916102 |
| 70 | MAP3K7 | 0.33126328 |
| 71 | EEF2K | 0.32366779 |
| 72 | SRC | 0.30702123 |
| 73 | HIPK2 | 0.29644643 |
| 74 | PDK1 | 0.29597247 |
| 75 | STK4 | 0.29540325 |
| 76 | ALK | 0.29244553 |
| 77 | CSNK1A1L | 0.28750291 |
| 78 | PRKCD | 0.26131654 |
| 79 | MARK3 | 0.25590189 |
| 80 | MAPK3 | 0.25448077 |
| 81 | CSNK1G3 | 0.24040730 |
| 82 | PRKG2 | 0.23557262 |
| 83 | CSNK1G1 | 0.22655992 |
| 84 | TAOK3 | 0.22417247 |
| 85 | STK16 | 0.20872064 |
| 86 | PKN2 | 0.20693081 |
| 87 | AURKB | 0.19363309 |
| 88 | MST4 | 0.18648616 |
| 89 | CAMK1 | 0.18565253 |
| 90 | TGFBR1 | 0.18155725 |
| 91 | PRKD1 | 0.17117700 |
| 92 | TYRO3 | 0.15195710 |
| 93 | ROCK2 | 0.15121703 |
| 94 | CHUK | 0.14651424 |
| 95 | MAPK9 | 0.14502886 |
| 96 | PRKCB | 0.14160979 |
| 97 | PASK | 0.13946974 |
| 98 | MAPK12 | 0.13615981 |
| 99 | PTK2 | 0.13206310 |
| 100 | PRKD2 | 0.12526461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.79127241 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.08153894 |
| 3 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.61879403 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.39369070 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.26737134 |
| 6 | Measles_Homo sapiens_hsa05162 | 3.16926309 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.14863073 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.46979872 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.39702323 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35799750 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.12192481 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98714164 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93394460 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 1.84311026 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83667650 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.82418063 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73104977 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.70703093 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.70289918 |
| 20 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.67837038 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.61691105 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.58874491 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56685712 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.45212966 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42565835 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39843855 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39813387 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14273256 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.13162963 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11450226 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.09501659 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08028217 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04459298 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00782902 |
| 35 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98099671 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 0.94585576 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93396045 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 0.89016048 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86574126 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 0.86428377 |
| 41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84795529 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 0.83685196 |
| 43 | RNA polymerase_Homo sapiens_hsa03020 | 0.81435612 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 0.77612121 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 0.75716138 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74289518 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.72672851 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71905067 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 0.71042607 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65859846 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.64869875 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 0.62607231 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.62107329 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59222394 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57086391 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55790943 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53518804 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52699724 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50068080 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.49683196 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.48333904 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45820052 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43349400 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41795272 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41564525 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41166009 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40120641 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39936603 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.38608067 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37498507 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35479335 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34594970 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34133380 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.33235033 |
| 75 | RNA degradation_Homo sapiens_hsa03018 | 0.32994284 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32745216 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.32643349 |
| 78 | Base excision repair_Homo sapiens_hsa03410 | 0.31531025 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30243708 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.26715651 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25114949 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19823464 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.18891058 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.18262387 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.15410707 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.14959125 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13802665 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.11231911 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.08426006 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07427212 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.05061289 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.02901056 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02696082 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.02345217 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.01860862 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.00080786 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0323726 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0115996 |
| 99 | RNA transport_Homo sapiens_hsa03013 | -0.0079359 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0027994 |

